Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shanghai Jiao Tong University School of Medicine | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor in primiparas so as to decrease perinatal complications of analgesia labor.
A prospective study of 120 full-term parturients receiving labor analgesia were randomly assigned into 2 groups: the 0.5Sufen group (N=60), the 0.25Sufen group (N=60).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 0.5 sufentanil | Experimental | 0.5µg/ml sufentanil, 0.1% ropivacaine for 6ml/h |
|
| 0.25 sufentanil | Experimental | 0.25µg/ml sufentanil, 0.1% ropivacaine for 6ml/h |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 0.25 sufentanil | Drug | with different dosage |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| VAS(visual analog pain score) | comparison with two groups | 1 year |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zeyong Yang, M.D. | Fudan University, Shanghai Jiaotong University | Principal Investigator |
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| SAP | No | Yes | No | Statistical Analysis Plan | Jun 30, 2016 | Aug 10, 2020 | SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D017409 | Sufentanil |
| D000077212 | Ropivacaine |
| D000779 | Anesthetics, Local |
| ID | Term |
|---|---|
| D005283 | Fentanyl |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 0.5µg/ml sufentanil | Drug | 0.5µg/ml sufentanil |
|
|
| 0.1% ropivacaine | Drug | 0.1% ropivacaine |
|
|
| D000813 |
| Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
| D000588 | Amines |
| D000777 | Anesthetics |
| D002492 | Central Nervous System Depressants |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |